Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cannabidiol Adjunctive Therapy for Acute Bipolar Depression: A Randomized Double-Blind, Placebo Controlled Trial

NCT05867849 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT05867849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05867849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cannabidiol Adjunctive Therapy for Acute Bipolar Depression: A Randomized Double-Blind, Placebo Controlled Trial
Lead sponsor
University of British Columbia
Phase
Phase 3
Overall status
Recruiting
Start date
October 15, 2023
Completion date
December 31, 2030
Enrollment
360 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder